Skyler Brand Ventures, an incubator of research and development for the cosmetics industry calls himself, he said, his Erasa XEP-30 brings together some of the advanced cutting-edge science of all products in the fight against facial aging category launched.
Skyler was established by the former Scientific Director and Head of Applied Research of Estee Lauder, Jules Zecchio who has created more than 20 years some of the best-selling product launches for the company.
The research and development team Skyler contains some of the biggest names in the formulation, as Dr. Konnie Lahanas, formerly of Limited Brands, whose combined talents to the creation of the first company, holding company, BioMimetic focused laboratories.
Biomimetics the bar
As the name suggests, the Division focused on the use of modern biotechnology products available skin care anti-aging with an efficiency that is said to create a new standard in the industry.
While biomimetic Laboratories has spent three years in the making, Erasa EXP-30 is just the first product launch was made possible by a partnership with Activate, the subsidiary of the Swiss cosmetics company Atheris born biotechnology laboratories.
The Global Alliance of R & D, which is the product of a product of skin care, which is said to provide a concentrated skin from aging cover on the back of the patent rights for Activate reference Euro peptides along to be taken care system with a patent pending for deep penetration in the skin.
The Results
The development team of the company, says that the end result is a product that helps to erase frown lines, including deep wrinkles and expression - while the elasticity and skin tone is restored.
The company says, "never seen" results reducing the age point in a history that includes the reduction of up to 92% of wrinkles, so that pores of 83% and 37% indicated that independent clinical laboratory tests.
"The remarkable clinical results are a confirmation of the structure of the research and the very fruitful cooperation Skyler and affiliated research company, which was very nice for our customers and investors is so good," said Zecchio.
"We are eager to establish themselves on the latest standard in the product efficacy and clinical trials in all societies and Skyler products industry."
No comments:
Post a Comment